Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice

Life Sciences

Volumn 75, Issue 7, 2004, Pages 869-880

  Sasaki, Minoru ^a   Uehara, Sayuri ^a   Ohta, Hisashi ^a   Taguchi, Kazuhiro ^a   Kemi, Masayuki ^a   Nishikibe, Masaru ^a   Matsumoto, Hiroyoshi ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Angiotensin II receptor antagonist; Diabetes; Glomerulopathy; KKAy mice; Losartan; Podocyte

Indexed keywords

ENALAPRIL; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE COURSE; GLOMERULUS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADMINISTRATION, ORAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; KIDNEY; KIDNEY GLOMERULUS; LOSARTAN; MALE; MICE; MICE, INBRED STRAINS; MICE, OBESE; ORGAN SIZE; RECEPTOR, ANGIOTENSIN, TYPE 1; WATER SUPPLY;

EID: 2942536127     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.01.022     Document Type: Article

References (29)

1. Aizawa-Abe M., Ogawa Y., Masuzaki H., Ebihara K., Satoh N., Iwai H., Matsuoka N., Hayashi T., Hosoda K., Inoue G., Yoshimasa Y., Nakao K. Pathophysiological role of leptin in obesity-related hypertension. The Journal of Clinical Investigation. 105:2000;1243-1252
2. Bell R.H., Fernandez-Cruz L., Brimm J.E., Sayers H.A., Lee S., Orloff M.J. Prevention by whole pancreas transplantation of glomerular basement membrane thickening in alloxan diabetes. Surgery. 88(1):1980;31-40
3. Bonnet F., Cooper M.E., Kawachi H., Allen T.J., Boner G., Gao Z. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia. 44:2001;874-877
4. Brenner B.M., Cooper M.E., Zeeuw D.D., Keane W.F., Mitch W.E., Parving H.-H., Remuzzi G., Snapinn S.M., Zhang Z., Shahinfar S. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. The New England Journal of Medicine. 345:2001;861-869
5. Brown D.M., Andres G.A., Hostetter T.H., Mauer S.M., Price R., Venkatachalam M.A. Kidney complication. Diabetes. 31(suppl. 1):1982;71-81
6. Brown D.M., Steffs M.W., Thibert P., Azar S., Mauer S.M. Glomerular manifestations of diabetes in the BB rat. Metabolism. 32:1983;131-135
7. Buck A.C., Reed P.I., Siddiq Y.K., Chisholm G.D., Fraser T.R. Bladder dysfunction and neuropathy in diabetes. Diabetologia. 12(3):1976;251-258
8. 1 angiotensin II receptor that is present in proximal tubule epithelium. American Journal of Physiology. 264:1993;F645-F654
9. Castle C.K., Colca J.R., Melchior G.W. Lipoprotein profile characterization of the KKAy mouse, a rodent model of type II diabetes, before and after treatment with insulin-sensitizing agent pioglitazone. Arteriosclerosis and Thrombosis. 13:1993;302-309
10. Diani A.R., Sawada G.A., Zhang N.Y., Wyse B.M., Cornell C.L., Vidmar T.J., Cornell M.A. The KKAy mouse: A model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels. 24:1987;297-303
11. Ernsberger P., Zhou J., Damon T.H., Douglas J.G. Angiotensin II receptor subtypes in cultured rat renal mesangial cells. American Journal of Physiology. 263:1992;F411-F416
12. Hirose K., Osterby R., Nozawa M., Gundersen H.J.G. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney International. 21:1982;689-695
13. Iwatsuka H., Shino A., Suzuoki Z. General survey of diabetic features of yellow KK mice. Folia Endoclinologica Japonica. 17:1970;23-35
14. Kim S., Wanibuchi H., Hamaguchi A., Miura K., Yamanaka S., Iwao H. Angiotensin blockade improves cardiac and renal complications of type II diabetic rats. Hypertension. 30:1997;1054-1061
15. Koike H. New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist. American Journal of Cardiology. 87(Suppl.):2001;33C-36C
16. Lafayette R.A., Mayer G., Park S.K., Meyer T.W. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. The Journal of Clinical Investigation. 90:1992;711-766
17. Leehey D.J., Singh A.K., Alavi N., Singh R. Role of angiotensin II in diabetic nephropathy. Kidney International. 58(suppl. 77):2000;S93-S98
18. Lewis E.J., Hunsicker L.G., Clarke W.R., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The New England Journal of Medicine. 329(20):1993;1456-1462
19. Like A.A., Lavine R.L., Poffenbarger P.L., Chick W.L. Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. The American Journal of Pathology. 66:1972;193-204
20. Mauer S.M. Structural-functional correlations of diabetic nephropathy. Kidney International. 45:1994;612-622
21. Morelli E., Loon N., Meyer T., Peters W., Myers B.D. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes. 39:1990;76-82
22. Ninomiya H., Inomata T., Ogihara K. Microvasculature of hydronephrotic kidney in KK-Ay mice. The Journal of Veterinary Medical Science. 62(10):2000;1093-1098
23. Ninomiya H., Inomata T., Ogihara K. Obstructive uropathy and hydronephrosis in male KK-Ay mice. The Journal of Veterinary Medical Science. 61(1):1999;53-57
24. Noda M., Matsuo T., Nagano-Tsuge H., Sekiguchi M., Ohta M., Sekiguchi M., Shibouta Y., Naka T., Imura Y. Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar Fatty rats). Japanese Journal of Pharmacology. 85:2001;416-422
25. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., Coplon N.S., Sun L., Meyer T.W. Podocyte loss and progressive glomerular injury in type II diabetes. The Journal of Clinical Investigation. 99(2):1997;342-348
26. Parving H.-H., Lehnert H., Brochener-Mortensen J., Gomis R., Andersen S., Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. The New England Journal of Medicine. 345(12):2001;870-878
27. Sharma M., Sharma R., Greene A.S., McCarthy E.T., Savin V.J. Documentation of angiotensin II receptors in glomerular epithelial cells. American Journal of Physiology. 274:1998;F623-F627
28. Uehara Y., Hirawa N., Kawabata Y., Numabe A., Gomi T., Ikeda T., Omata M. Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non-insulin-dependent diabetes mellitus. American Journal of Hypertension. 12:1999;21-27
29. Yotsumoto T., Naitoh T., Shikada K., Tanaka S. Effect of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice. Japanese Journal of Pharmacology. 75:1997;59-64